Merck Comprehensive Income 2012-2026 | MRK

Merck comprehensive income for the quarter ending March 31, 2026 was $-5.202B, a 3.15% decline year-over-year.

  • Merck comprehensive income for 2024 was $-4.945B, a 4.19% decline from 2023.
  • Merck comprehensive income for 2023 was $-5.161B, a 8.24% increase from 2022.
  • Merck comprehensive income for 2022 was $-4.768B, a 7.65% increase from 2021.

Merck Comprehensive Income 2012-2026 | MRK

  • Merck comprehensive income for 2024 was $-4.945B, a 4.19% decline from 2023.
  • Merck comprehensive income for 2023 was $-5.161B, a 8.24% increase from 2022.
  • Merck comprehensive income for 2022 was $-4.768B, a 7.65% increase from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Pfizer (PFE)$153.1B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B